Biological therapies are an effective treatment for a range of immune-mediated inflammatory
diseases (IMIDs), including rheumatoid arthritis, psoriasis, and inflammatory bowel …

Rheumatoid arthritis (RA) is a systemic inflammatory autoimmune disease predominantly
affecting middle-aged women. Very commonly, pain is a manifestation of active disease and …

Interrupted time series (ITS) analysis is being increasingly used in epidemiology. Despite its
growing popularity, there is a scarcity of guidance on power and sample size considerations …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a
global pandemic of severe coronavirus disease 2019 (COVID-19). Staphylococcus aureus is …

Aims Contemporary outcomes of primary total hip arthroplasties (THAs) with highly cross-
linked polyethylene (HXLPE) liners in patients with inflammatory arthritis have not been well …

Objectives Since 2010, biological disease‐modifying antirheumatic drugs (bDMARDs) have
been the dominant mode of treatment for rheumatoid arthritis (RA). However, the safety of …

Introduction Over the past several decades, management of rheumatoid arthritis (RA) has
evolved significantly, but few studies have examined the real-world impact of these changes …

Objectives To determine whether the introduction of biological DMARDs (bDMARDs) was
associated with reduced incidences of total hip and knee arthroplasty (THA/TKA) among …

Recent advancements in the treatment of psoriatic arthritis (PsA) have improved patient
outcomes, but many still experience disease progression, potentially leading to joint …

The third decade of the 21st century marks the beginning of a new era in the treatment of
rheumatoid arthritis (RA). Recently, after the introduction in clinical practice of different …